Modulation by fluoxetine of striatal dopamine release following Δ9-tetrahydrocannabinol: A microdialysis study in conscious rats

British Journal of Pharmacology

Volumn 128, Issue 1, 1999, Pages 21-26

  Malone, Daniel T ^a   Taylor, David A ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

9 THC; 5 HT; Dopamine; Fluoxetine; Microdialysis

Indexed keywords

AUTORECEPTOR; DOPAMINE; DRONABINOL; FLUOXETINE; RIMONABANT; SEROTONIN; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN PERFUSION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG POTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CONSCIOUSNESS; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; MALE; MICRODIALYSIS; PERFUSION; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TETRAHYDROCANNABINOL; TIME FACTORS;

EID: 0032880428     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702753     Document Type: Article

References (42)

1. Adell, A. & Artigias, F. (1991). Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study. Naunyn-Schmiedeberg's Arch. Pharmacol., 343, 237-244.
2. 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol. Rev., 38, 21-43.
3. Anderson, J.J., Kask, A.M. & Chase, T.N. (1996). Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists. Eur. J. Pharmacol., 295, 163-168.
4. Benloucif, S. & Galloway, M.P. (1991). Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur. J. Pharmacol., 200, 1-8.
5. Blandina, P., Goldfarb, J., Craddock Royal, B. & Green, J.P. (1989). Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum. J. Pharmacol. Exp. Ther., 251, 803-809.
6. 3 antagonist on drug-induced stimulation of dopamine release. Eur. J. Pharmacol., 164, 515-519.
7. 9-tetrahydrocannabinol produces naloxone-blockade enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology, 102, 156-162.
8. 9-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex. Eur. J. Pharmacol., 190, 259-262.
9. 9-tetrahydrocannabinol on body temperature in mice. Psychopharmacology, 69, 299-305.
10. Dewey, W.L. (1986). Cannabinoid pharmacology. Pharmacol. Rev., 38, 151-178.
11. Gardner, E.L. & Lowinson, J.H. (1991). Marijuana's interaction with brain reward systems: update 1991. Pharmacol. Biochem. Behav., 40, 571-580.
12. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol., 115, 1064-1070.
13. Grinspoon, L. & Bakalar, J. (1993). Marihuana: The Forbidden Medicine. New Haven: Yale University Press.
14. Herkenham, M., Lynn, A.B., De Costa, B.R. & Richfield, E.K. (1991). Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res., 547, 267-274.
15. Herkenham, M., Lynn, A.B., Little, M.D., Johnson, M.R., Melvin, L.S., De Costa, B.R. & Rice, K.C. (1990). Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U.S.A., 87, 1932-1936.
16. Hurd, Y.L. & Ungerstedt, U. (1989). Cocaine: an in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum. Synapse, 3, 48-54.
17. 1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus. Neuropharmacology, 36, 467-473.
18. 1 receptors on peripheral sympathetic nerves. Br. J. Pharmacol., 118, 2023 -2028.
19. 3H]dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: a comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid and D-amphetamine. J. Pharmacol. Exp. Ther., 262, 356-364.
20. 9-tetrahydrocannabinol on neurotransmitter accumulation and release mechanisms in rat forebrain synaptosomes. Life Sci., 19, 347-356.
21. 1 receptors. Eur. J. Pharmacol., 334, R1-2.
22. 2 receptors. Br. J. Pharmacol., 124, 619-622.
23. 9-tetrahydrocannabinol. 4th IUPHAR Satellite Meeting on Serotonin. pp. 117. Rotterdam.
24. 9-tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat. Br. J. Pharmacol., 124, 1419-1424.
25. Matsumoto, M., Yoshioka, M., Togashi, H., Tochihara, M., Ikeda, T. & Saito, H. (1995). Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis. J. Pharmacol. Exp. Ther., 272, 1044-1051.
26. Navarro, M., Rodriguez De Fonseca, F., Hernandez, M.L., Ramos, J.A. & Fernandez Ruiz, J.J. (1994). Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids. Pharmacol. Biochem. Behav., 47, 47-58.
27. Nedergaard, S., Bolam, J.P. & Greenfield, S.A. (1988). Facilitation of a dendritic calcium conductance by 5-hydroxytryptamine in the suhstantia nigra. Nature, 333, 174-177.
28. 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study. Brain Res., 451, 59-68.
29. Paxinos, G. & Watson, C. (1986). The Rat Brain in Stereotaxic Coordinates. Sydney: Academic Press.
30. Perry, K.W. & Fuller, R.W. (1992). Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci., 50, 1683-1690.
31. 1 receptors in mouse urinary bladder. Br. J. Pharmacol., 118, 2053-2058.
32. Pullar, I.A. & Findlay, J.D. (1992). Effect of voltage-sensitive calcium channel antagonists on the release of 5-hydroxytryplamine from rat hippocampus in vivo. J. Neurochem., 59, 553-559.
33. Richardson, J.D., Aanonsen, L. & Hargreaves, K.M. (1997). SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice. Eur. J. Pharmacol., 319, R3-4.
34. Rutter, J.J. & Auerbach, S.B. (1993). Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J. Pharmacol. Exp. Ther., 265, 1319-1324.
35. 9-tetrahydrocannabinol facilitates striatal dopaminergic transmission. Pharmacol. Biochem. Behav., 33, 397-400.
36. 2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine. Eur. J. Pharmacol., 223, 65-74.
37. 1 receptor. Eur. J. Pharmacol., 157, 173-181.
38. 1-tetrahydrocannabinol on serotonin metabolism in the rat brain. Life Sci., 10, 425-436.
39. Tanda, G., Pontieri, F.E. & Di Chiara, G. (1997). Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mul opioid receptor mechanism. Science, 276, 2048-2050.
40. 9-tetrahydrocannabinol treatment. J. Pharm. Pharmacol., 30, 654-656.
41. 9-tetrahydrocannabinol. Psychopharmacology, 68, 261-267.
42. Yadid, G., Pacak, K., Kopin, I.J. & Goldstein, D.S. (1994). Endogenous serotonin stimulates striatal dopamine release in conscious rats. J. Pharmacol. Exp. Ther., 270, 1158-1165.